Hormonal Contraceptives Market Clinical Analysis and Research Report 2020
The New report includes a detailed study of Global Hormonal Contraceptives Market. It is the result of a comprehensive research carried out keeping in mind the different parameters and trends dominating the global Hormonal Contraceptives Market. Both primary and secondary research has been carried out to arrive at the desired outcome. The primary research included feedback, opinion, and suggestion provided by the people and organization residing in the key markets as identified the industry experts.
The global hormonal contraceptives market was valued at about $13.36 billion in 2018 and is expected to grow to $15.39 billion at a CAGR of 3.6% through 2022.
Get an Insightful Report Sample Here @
Top Key Players Profiled in This Report:
Bayer AG, Merck & Co. Inc., Pfizer, Allergan and Afaxys Inc.
Increased awareness about the benefits and use of contraceptives is a major factor driving the hormonal contraceptives market. According to the World Health Organization (WHO), 16 million girls worldwide aged 15-19 give birth every year which accounts to approximately 11% of all births globally. In order to prevent these unplanned births global awareness programs such as “”Its your life, its your future”” by the WHO and world contraception day were initiated. The London Summit on Family Planning urged governments, international agencies, and other private sector to commit to improving access to voluntary family planning. This gave rise to the global partnership, Family Planning 2020 (FP2020). FP2020 has created a momentum worldwide on issues such as access to contraceptives, more innovation, and greater accountability in family planning efforts. For example, India committed to spend USD$3 billion by 2020 to spread awareness improve family planning in the country. Moreover, in 2015, it was estimated that approximately 64% of married women aged between 15 and 49 used either a modern or traditional method of family planning, an increase from 36% in 1970.
The market for hormonal contraceptive drugs is restrained by the growing use of biologics in place of traditional chemical drugs. Biologics are the medicines containing one or more substances derived from a biological source like micro-organisms, animal cells or human cells. The ability to interact with specific targets puts these medicines above any other drugs, thus hampering the market of chemical hormonal contraceptive drugs.
Companies are innovating to manufacture chewable low dose oral contraceptives that reduce side effects. Chewable contraceptive initiative was an attempt to reduce side effects while at the same time making it easier for the patients to get into a daily regimen of using this contraceptive. The pill is already being sold as an over the counter product. Some of the top companies that produce and sell chewable low-dose oral contraceptives, for instance, are Lupin pharmaceuticals, Walter Chilcott and Watson pharmaceuticals.
Inquiry For Discount:
Scope of the Report:
Markets Covered: 1) By Product: Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Others 2) By End Users: Hospitals, Homecare Settings, Gynaecology Centers, Clinics, Ambulatory surgical centers
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Hormonal Contraceptives Indicators Comparison.
Reasons to Purchase
- Outperform competitors using accurate up to date demand-side dynamics information.
- Identify growth segments for investment.
- Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
- Create regional and country strategies on the basis of local data and analysis.
- Stay abreast of the latest customer and market research findings
- Benchmark performance against key competitors.
- Develop strategies based on likely future developments.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Gain a global perspective on the development of the market.
Get complete [email protected]
This research report represents a 360-degree overview of the competitive landscape of the Global Hormonal Contraceptives Market. Furthermore, it offers massive data relating to recent trends, technological advancements, tools, and methodologies. The research report analyzes the Global Hormonal Contraceptives Market in a detailed and concise manner for better insights into the businesses. Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Hormonal Contraceptives Market. The feasibility of the new report is also measured in this research report.
We also offer customization on reports based on specific client requirement:
1- Free country level analysis for any 5 countries of your choice.
2- Free Competitive analysis of any market players.
3- Free 40 analyst hours to cover any other data points
Irfan Tamboli (Sales)
Phone: + 1704 266 3234